Edition:
India

Vitrolife AB (VITR.ST)

VITR.ST on Stockholm Stock Exchange

135.26SEK
3:51pm IST
Change (% chg)

-3.18kr (-2.30%)
Prev Close
138.44kr
Open
139.50kr
Day's High
139.50kr
Day's Low
135.10kr
Volume
30,581
Avg. Vol
149,644
52-wk High
143.86kr
52-wk Low
100.40kr

Chart for

About

Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a... (more)

Overall

Beta: 0.58
Market Cap(Mil.): kr14,480.65
Shares Outstanding(Mil.): 21.71
Dividend: 2.60
Yield (%): 0.39

Financials

BRIEF-Vitrolife Q1 operating profit rises

* VITROLIFE AB Q1 OPERATING INCOME BEFORE DEPRECIATION AND AMORTISATION (EBITDA) AMOUNTED TO SEK 106 (95) MILLION Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

24 Apr 2018

BRIEF-Vitrolife hikes dividend, Q4 EBITDA up yr/yr

* Q4 ‍SALES AMOUNTED TO SEK 271 (251) MILLION, CORRESPONDING TO AN INCREASE OF 8 PERCENT IN SEK​

08 Feb 2018

BRIEF-Vitrolife says Embryoscope approved for sales in China

* SAYS ‍HAS TODAY RECEIVED MARKET APPROVAL FOR TIME-LAPSE INCUBATOR EMBRYOSCOPE IN CHINA​ Source text for Eikon: Further company coverage: (Stockholm Newsroom)

01 Feb 2018

BRIEF-Vitrolife buys licensing rights for embryo transfer technology

* VITROLIFE ACQUIRES LICENSING RIGHTS TO TECHNOLOGY FOR EMBRYO TRANSFER

11 Jan 2018

Earnings vs. Estimates